Forum Topic News
  • Conversation: EC approves Pfizer's Herceptin biosimilar

    • July 31, 2018 1:54 PM BST
    • EC approves Pfizer's Herceptin biosimilar

      Pfizer's Herceptin (trastuzumab) biosimlar Trazimera has been approved by the European Comission.
      Trazimera is the company's first oncology biosimilar and fourth biosimilar overall to receive European approval. Like its originator it will be licesnced to treat human epidermal growth factor (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
      Read more: http://www.pharmatimes.com/news/ema_approves_pfizers_herceptin_biosimilar_1246372

Add Reputation

Do you want to add reputation for this member by this post?

or cancel
‚Äč